11 completed, 1 no longer available, 1 terminated. 7 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 6, Terminated 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow tin mesoporphyrin: new trials by email Literature Review of tin mesoporphyrin trials Research Report on tin mesoporphyrin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Follow up Study of Patients Having Participated in Clinical Trial 64,185-204 Stannsoporfin, Placebo - Hyperbilirubinemia, Neonatal | Completed | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 68 | 2013-10-17 | 2021-02-02 | |
| Stannsoporfin With Light Therapy for Newborn Babies With Jaundice Phototherapy, Stannsoporfin, Placebo - Jaundice, Neonatal, Hyperbilirubinemia, Neonatal | Phase 2 | Completed | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 91 | 2013-10-16 | 2020-02-06 |
| Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993) Stannsoporfin, Placebo Control, Phototherapy (as needed) - Jaundice, Neonatal Hyperbilirubinemia | Completed | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 42 | 2008-10-20 | 2019-10-15 | |
| A Safety and Efficacy Trial of Stannsoporfin in Neonates With Hyperbilirubinemia Stannsoporfin, Placebo, PhotoTherapy (as needed) - Hyperbilirubinemia, Neonatal | Phase 2 | Terminated | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 58 | 2008-08-01 | 2019-10-30 |
| Safety and Pharmacology of Stanate Stanate - Hyperbilirubinemia | Phase 2 | Completed | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 55 | 2005-09-01 | 2019-10-15 |
| Efficacy and Safety of Stannsoporfin in Neonates stannsoporfin, Sham Injection - Nutritional and Metabolic Diseases | Phase 3 | Completed | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 185 | 2002-05-01 | 2019-10-29 |
| Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns tin mesoporphyrin, Phototherapy - Hyperbilirubinemia | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 80 | 1999-12-01 | 2008-09-09 |
| Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia tin mesoporphyrin - Glucosephosphate Dehydrogenase Deficiency, Hyperbilirubinemia | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1999-12-01 | 2005-06-24 | |
| Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria heme arginate, tin mesoporphyrin - Porphyria | Phase 1 | Completed | National Center for Research Resources (NCRR) | 24 | 1998-01-01 | 2005-06-24 |
| Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria heme arginate, tin mesoporphyrin - Porphyria | Phase 1 | Completed | National Center for Research Resources (NCRR) | 20 | 1998-01-01 | 2005-06-24 |
| Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias heme arginate, tin mesoporphyrin - Porphyria | Phase 2 | Completed | National Center for Research Resources (NCRR) | 32 | 1997-09-01 | 2005-06-24 |
| Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria heme arginate, tin mesoporphyrin - Porphyria | Phase 1 / Phase 2 | Completed | National Center for Research Resources (NCRR) | 59 | 1993-07-01 | 2005-06-24 |
| Compassionate Use of Stanate (TM) [Stannsoporfin] Stanate (TM) [stannsoporfin, tin-mesoporphyrin] - Neonatal Jaundice, Hyperbilirubinemia | No longer available | InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company | 2019-10-15 |
Hyperbilirubinemia (6) · Rare Diseases (6) · Hyperbilirubinemia, Neonatal (5) · Metabolism, Inborn Errors (4) · Porphyrias (4) · Jaundice (3) · Jaundice, Neonatal (3) · Glucosephosphate Dehydrogenase Deficiency (2) · Hematologic Diseases (2) · Erythroblastosis, Fetal (1) · Hemolysis (1) · Infant, Newborn, Diseases (1) · Kernicterus (1) · Nutritional and Metabolic Diseases (1) · Porphyria, Acute Intermittent (1)
InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company (7) · National Center for Research Resources (NCRR) (4) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)
United States (6) · Poland (1) · Spain (1) · Ukraine (1) · Vietnam (1)
Karl Elmo Anderson (4) · Attallah Kappas (2)
2009 (1)